Lawrence A. Kenyon
2019
In 2019, Lawrence A. Kenyon earned a total compensation of $1.9M as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 160% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,419,880 |
|---|---|
| Salary | $425,000 |
| Other | $19,021 |
| Total | $1,863,901 |
Kenyon received $1.4M in option awards, accounting for 76% of the total pay in 2019.
Kenyon also received $425K in salary and $19K in other compensation.
Rankings
In 2019, Lawrence A. Kenyon's compensation ranked 6,290th out of 13,971 executives tracked by ExecPay. In other words, Kenyon earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,290 out of 13,971 | 55th |
Division Manufacturing | 2,364 out of 5,701 | 59th |
Major group Chemicals And Allied Products | 863 out of 2,200 | 61st |
Industry group Drugs | 730 out of 1,886 | 61st |
Industry Biological Products, Except Diagnostic Substances | 172 out of 389 | 56th |
Source: SEC filing on February 22, 2021.